Global Injectable Drug Market: Size, Trends and Forecasts 2016-2020 - Pfizer Dominates the Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)" report to their offering.

The report titled Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along with the market size of each market segment.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global injectable drug market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc.

Further, key players of the injectable drug market such as Merck & Co., Inc., Novartis AG and Johnson & Johnson are also profiled with their financial information and respective business strategies.

Company Coverage:

- Pfizer, Inc.

- Merck & Co., Inc.

- Novartis AG

- Johnson & Johnson

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Introduction to Injectable Drugs

2.2 Types of Injectable Drugs

2.3 Types of Injectable Routes

3. Global Market Analysis

3.1 Global Injectable Drug Market by Value

3.2 Global Injectable Drug Market by Segments

3.2.1 Global Injectable Vaccine Market by Value

3.2.2 Global Injectable Insulin Market by Value

3.2.3 Global Injectable Conventional Therapeutics Market by Value

3.2.4 Global Injectable Complex Biologics Market by Value

3.3 Global Injectable Drug Market as a Share of Total Drug Market

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Increase in Cancer Incidences

4.1.2 Rise in Diabetic Population

4.1.3 Introduction of New Products

4.1.4 Increase in Biologics and New Drugs License Approvals

4.2 Challenges

4.2.1 High Risk of Re-operation or Death

4.2.2 Injectable Drug Safety Issues

4.2.3 Less Patient Compliance

4.3 Market Trends

4.3.1 Technological Innovations in the Global Injectable Delivery Market

4.3.2 Evolution of Combination Products

4.3.3 Injectable Drugs Packaging

4.3.4 Flexible Manufacturing

4.3.5 Biosimilars

5. Competitive Landscape

5.1 Pharmaceutical Companies Ranking

5.2 Pharmaceutical Companies Brand Value

6. Company Profiling

For more information visit http://www.researchandmarkets.com/research/5th9ft/global_injectable

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables